Business Insider

Swissmedic approves Buvidal for the treatment of opioid dependence

LUND, Sweden, Dec. 18, 2020 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ® ...
Business Insider

Camurus Announces Publication of Phase 3 Study Results Showing Long-term Safety, Efficacy and High Rates of Patient Satisfaction With Buvidal®

- Individualized treatment of opioid dependence with weekly and monthly Buvidal ® was well-tolerated and effective, with a high (73.6%) patient retention across the 48-week study - 83.4% of ...
Pharmabiz

Camurus DEBUT study of weekly & monthly Buvidal versus standard of care to treat opioid dependence meets primary endpoint

Camurus, a Swedish, science-led biopharmaceutical company, announced topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal (prolonged-release ...
Pharmabiz

Camurus’ Buvidal receives Swissmedic marketing approval to treat opioid dependence

Camurus AB, a Swedish, science-led biopharmaceutical company, announced that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal prolonged release ...
Nasdaq

Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence

LUND, Sweden, Nov. 26, 2019 /PRNewswire/ -- Camurus announced today topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal® (prolonged-release ...
News Medical

Buvidal Weekly and Buvidal Monthly

The full CMI on the next page has more details. If you are worried about being given this medicine, speak to your doctor, nurse practitioner or pharmacist. Buvidal contains the active ingredient ...
BBC

Buvidal drug treatment 'like being given a new life'

A recovering heroin addict says a new treatment being trialled in the West Midlands is like "being given the keys to a new life". Buvidal is a monthly injection that replaces daily treatments like ...
Nasdaq

Positive Treatment Results for Buvidal® in Fentanyl Users Presented at the ASAM 50th Annual Conference

Phase 3 post-hoc analysis indicates less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment in a difficult to treat patient population LUND ...
PR Newswire

Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence

LUND, Sweden, Nov. 28, 2018 /PRNewswire/ -- Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company's lead products Buvidal® Weekly and Buvidal® ...
The Conversation

Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?

Buvidal, or long-acting injectable buprenorphine, was approved for use in the UK in 2019. Tribune Content Agency LLC/Alamy But not all those on substitute medication are able to stop using illicit ...
BBC

Buvidal drug treatment 'like being given a new life'

A recovering heroin addict says a new treatment being trialled in the West Midlands is like "being given the keys to a new life". Buvidal is a monthly injection that replaces daily treatments like ...